# Combination Chemotherapy in Treating Women With Breast Cancer

> **NCT00047099** · PHASE3 · COMPLETED · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 446 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** docetaxel
- **DRUG:** epirubicin hydrochloride
- **DRUG:** fluorouracil
- **DRUG:** goserelin acetate
- **DRUG:** tamoxifen citrate
- **PROCEDURE:** adjuvant therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00047099
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-08
- **Primary completion:** 2012-02
- **Final completion:** 2012-03
- **Target enrollment:** 446 (ESTIMATED)
- **Last updated:** 2013-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00047099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00047099, "Combination Chemotherapy in Treating Women With Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00047099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*